Clinical Trial: Effects of Neuralli(R) MP on Self-Defined Outcomes in Adults With Autistic Traits

U.S., July 15 -- ClinicalTrials.gov registry received information related to the study (NCT07064538) titled 'Effects of Neuralli(R) MP on Self-Defined Outcomes in Adults With Autistic Traits' on July 11.

Brief Summary: To evaluate the efficacy of Neuralli(R) MP in improving participant-defined outcomes in adults with autistic traits.

Study Start Date: Aug. 15

Study Type: INTERVENTIONAL

Condition: ASD Autism Autistic Disorders Spectrum

Intervention: DIETARY_SUPPLEMENT: Neuralli(R) MP

Neuralli(R) MP containing 60 billion CFU (administered as two capsules per day)

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Mackay Memorial Hospital

Disclaimer: Curated by HT Syndication....